Jill Van Dalfsen is the Director of Network and Clinical Trial Operations at the CFFT Therapeutics Development Network Coordinating Center (CFFT-TDNCC). Her background includes ten years as a clinical microbiology Medical Technologist and two years of teaching medical laboratory science before moving to the pharmaceutical industry. Prior to joining the CFFT-TDNCC in 2007, she spent 10 years working in pharmaceutical lead discovery, clinical development and global medical affairs for PathoGenesis and Chiron and consulted for two years with multiple other pharmaceutical companies on clinical trial design and implementation. Jills areas of expertise include clinical trial management, FDA regulations for drug development and approval, and good clinical practices.
DG25--RC Updates & Special Topics
Saturday, September 28, 2024
7:45 AM – 9:45 AM ET